Literature DB >> 7299348

Somatically generated mouse myeloma variants synthesizing IgA half-molecules.

D J Zack, S L Morrison, W D Cook, W Dackowski, M D Scharff.   

Abstract

Whereas mouse myelomas that secrete IgA half-molecules have been shown to arise in vivo, their origin has not been definitely established. We show that somatic variants secreting phenotypically similar molecules can arise directly from the normal IgA-secreting myelomas S107 and W3082. In addition to being improperly assembled, the variant proteins have distinct carboxy-terminal deletions and an aberrant heavy-light chain disulfide bond. For at least one of the variants, variable region serology and affinity for hapten are both unaffected by these changes. Southern and Northern blot analyses indicate normal size DNA restriction fragments and mRNA, suggesting premature termination as the mechanism of deletion. These results are discussed in relation to possible mutational hot spots and long-range interdomain interactions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7299348      PMCID: PMC2186520          DOI: 10.1084/jem.154.5.1554

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

1.  Heterogeneity in dextran preparations.

Authors:  C A WILHAM; B H ALEXANDER; A JEANES
Journal:  Arch Biochem Biophys       Date:  1955-11       Impact factor: 4.013

2.  Chain models of 6.6S and 3.9S mouse myeloma gamma A immunoglobulin molecules.

Authors:  T Seki; E Appella; H A Itano
Journal:  Proc Natl Acad Sci U S A       Date:  1968-11       Impact factor: 11.205

3.  Studies on the structure of mouse gamma-A myeloma proteins.

Authors:  C A Abel; H M Grey
Journal:  Biochemistry       Date:  1968-07       Impact factor: 3.162

4.  Characterization of the antibody to the C-carbohydrate produced by a transplantable mouse plasmacytoma.

Authors:  M Cohn; G Notani; S A Rice
Journal:  Immunochemistry       Date:  1969-01

5.  Affinity labeling of a phosphorylcholine binding mouse myeloma protein.

Authors:  B Chesebro; H Metzger
Journal:  Biochemistry       Date:  1972-02-29       Impact factor: 3.162

6.  Binding of diffusible molecules by macromolecules: rapid measurement by rate of dialysis.

Authors:  S P Colowick; F C Womack
Journal:  J Biol Chem       Date:  1969-02-25       Impact factor: 5.157

7.  Somatic variants in mouse myeloma and hybridoma cell lines.

Authors:  D E Yelton; W D Cook; M D Scharff
Journal:  Transplant Proc       Date:  1980-09       Impact factor: 1.066

8.  Resolution of multiple ribonucleic acid species by polyacrylamide gel electrophoresis.

Authors:  A C Peacock; C W Dingman
Journal:  Biochemistry       Date:  1967-06       Impact factor: 3.162

9.  Nucleic acid and protein sequences of phosphocholine-binding light chains.

Authors:  S P Kwan; S Rudikoff; J G Seidman; P Leder; M D Scharff
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

10.  Common individual antigenic determinants in five of eight BALB-c IgA myeloma proteins that bind phosphoryl choline.

Authors:  M Potter; R Lieberman
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

View more
  7 in total

1.  Expression and characterization of an antibody binding specificity joined to insulin-like growth factor 1: potential applications for cellular targeting.

Authors:  S U Shin; S L Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

2.  Identification of mutant monoclonal antibodies with increased antigen binding.

Authors:  R R Pollock; D L French; M L Gefter; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

3.  Selective removal of alpha heavy-chain glycosylation sites causes immunoglobulin A degradation and reduced secretion.

Authors:  A K Taylor; R Wall
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

Review 4.  How antibodies fold.

Authors:  Matthias J Feige; Linda M Hendershot; Johannes Buchner
Journal:  Trends Biochem Sci       Date:  2009-12-21       Impact factor: 13.807

5.  Loss of a consensus splice signal in a mutant immunoglobulin gene eliminates the CH1 domain exon from the mRNA.

Authors:  C R Brandt; S L Morrison; B K Birshtein; C Milcarek
Journal:  Mol Cell Biol       Date:  1984-07       Impact factor: 4.272

6.  Point mutations cause the somatic diversification of IgM and IgG2a antiphosphorylcholine antibodies.

Authors:  N C Chien; R R Pollock; C Desaymard; M D Scharff
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

7.  Assembly and secretion of heavy chains that do not associate posttranslationally with immunoglobulin heavy chain-binding protein.

Authors:  L Hendershot; D Bole; G Köhler; J F Kearney
Journal:  J Cell Biol       Date:  1987-03       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.